Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The unleashing of the immune system in COVID-19 and sepsis: the calm before the storm?
Salvatore Bellinvia, Christopher J Edwards, Matteo Schisano, et al.
Inflammation Research (2020) Vol. 69, Iss. 8, pp. 757-763
Open Access | Times Cited: 24

Showing 24 citing articles:

Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19
Can Liu, Andrew J. Martins, William Lau, et al.
Cell (2021) Vol. 184, Iss. 7, pp. 1836-1857.e22
Open Access | Times Cited: 206
Optical Coherence Tomography Angiography Features in Post-COVID-19 Pneumonia Patients: A Pilot Study
Gilda Cennamo, Michele Reibaldi, Daniela Montorio, et al.
American Journal of Ophthalmology (2021) Vol. 227, pp. 182-190
Open Access | Times Cited: 82
COVID-19 and Sepsis
Zeliha Koçak Tufan, Bircan Kayaaslan, Mervyn Mer
TURKISH JOURNAL OF MEDICAL SCIENCES (2021) Vol. 51, Iss. SI-1, pp. 3301-3311
Open Access | Times Cited: 73
Severe COVID-19 and Sepsis: Immune Pathogenesis and Laboratory Markers
Mai M. Zafer, Hadir A. El‐Mahallawy, Hossam M. Ashour
Microorganisms (2021) Vol. 9, Iss. 1, pp. 159-159
Open Access | Times Cited: 70
SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: Future predictions
Tarek M. Abdelghany, Magdah Ganash, Marwah M. Bakri, et al.
Biomedical Journal (2020) Vol. 44, Iss. 1, pp. 86-93
Open Access | Times Cited: 58
Risk factors for severity of COVID-19 in hospital patients age 18–29 years
Micaela Sandoval, Duc T. Nguyen, Farhaan Vahidy, et al.
PLoS ONE (2021) Vol. 16, Iss. 7, pp. e0255544-e0255544
Open Access | Times Cited: 47
Regulation of acute reflectory hyperinflammation in viral and other diseases by means of stellate ganglion block. A conceptual view with a focus on Covid-19
Lorenz Fischer, Hans Barop, Sabina Ludin, et al.
Autonomic Neuroscience (2021) Vol. 237, pp. 102903-102903
Open Access | Times Cited: 42
Chemical profiling of Huashi Baidu prescription, an effective anti-COVID-19 TCM formula, by UPLC-Q-TOF/MS
Wenlong Wei, Shifei Wu, Haojv Li, et al.
Chinese Journal of Natural Medicines (2021) Vol. 19, Iss. 6, pp. 473-480
Open Access | Times Cited: 27
Resveratrol and Copper for treatment of severe COVID-19: an observational study (RESCU 002)
Indraneel Mittra, Rosemarie de Souza, Rakesh Bhadade, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 26
The evolving direct and indirect platforms for the detection of SARS-CoV-2
Sonia Fathi‐karkan, Reza Maleki Baladi, Mehdi Shahgolzari, et al.
Journal of Virological Methods (2021) Vol. 300, pp. 114381-114381
Open Access | Times Cited: 21
Retinal microvascular morphology versus COVID-19: What to anticipate?
Özgür Eroğul, Hamıdu Hamısı Gobeka, Mustafa Doğan, et al.
Photodiagnosis and Photodynamic Therapy (2022) Vol. 39, pp. 102920-102920
Open Access | Times Cited: 15
Septic cardiomyopathy: characteristics, evaluation, and mechanism
Wanlin Xue, Jiaojiao Pang, Jiao Liu, et al.
Emergency and Critical Care Medicine (2022) Vol. 2, Iss. 3, pp. 135-147
Open Access | Times Cited: 12
Systems Pharmacology and Verification of ShenFuHuang Formula in Zebrafish Model Reveal Multi-Scale Treatment Strategy for Septic Syndrome in COVID-19
Tengwen Liu, Yuhong Guo, Jingxia Zhao, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 17
Acute neutrophilic vasculitis (leukocytoclasia) in 36 COVID-19 autopsy brains
Roy H. Rhodes, Gordon L. Love, Fernanda Da Silva Lameira, et al.
Diagnostic Pathology (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Identification of diagnostic candidate genes in COVID‐19 patients with sepsis
Jiuang Li, Shiqian Pu, Lei Shu, et al.
Immunity Inflammation and Disease (2024) Vol. 12, Iss. 10
Open Access | Times Cited: 1
Relationship between COVID-19 and ICU-Acquired Bloodstream Infections Related to Multidrug-Resistant Bacteria
Antoine Piantoni, Marion Houard, Gaetan Piga, et al.
Antibiotics (2023) Vol. 12, Iss. 7, pp. 1105-1105
Open Access | Times Cited: 4
Do Ocular Fluids Represent a Transmission Route of SARS-CoV-2 Infection?
Giulio Petronio Petronio, Roberto Di Marco, Ciro Costagliola
Frontiers in Medicine (2021) Vol. 7
Open Access | Times Cited: 11
Assessment of the optic nerve, macular, and retinal vascular effects of COVID-19
Adem Uğurlu, Sümeyye Burcu Ağcayazi, Erel İçel, et al.
Canadian Journal of Ophthalmology (2022) Vol. 58, Iss. 6, pp. 570-576
Open Access | Times Cited: 5
Substantial heterogeneity of inflammatory cytokine production and its inhibition by a triple cocktail of toll-like receptor blockers in early sepsis
Willem Buys, Alexandra Bick, Rabea J. Madel, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 2
Magnitude of Septic Shock and its Associated Factors Among Critically Ill COVID-19 Patients at Addis Ababa COVID-19 Care Centers, Ethiopia
Kasie Gebeyehu Tiruneh, Migbar Mekonnen Sibhat, Melsew Getnet Tsegaw, et al.
SAGE Open Nursing (2024) Vol. 10
Open Access
Differential Immune Checkpoint and Ig-like V-Type Receptor Profiles in COVID-19: Associations with Severity and Treatment
Roberto Lozano‐Rodríguez, Verónica Terrón‐Arcos, Raúl López, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 12, pp. 3287-3287
Open Access | Times Cited: 2
Potential therapeutic agents against COVID-19 based on blocking and inhibition of the viral life cycle and the cytokine storm syndrome
Gabriel Soto
Anales de la Facultad de Ciencias Médicas (Asunción) (2020) Vol. 53, Iss. 3, pp. 131-146
Open Access | Times Cited: 1
Up-Regulation of miR-1925 by Bone Marrow Mesenchymal Stem Cell (BMSC) Inhibits the Growth of Liver Cancer by Promoting the Anti-Tumor Activity of Natural Killer (NK) Cells
Chencheng Ding, Yunjie Zheng, Dan Li, et al.
Journal of Biomaterials and Tissue Engineering (2022) Vol. 12, Iss. 3, pp. 630-633
Closed Access
COVID‐19: Immunology
Yasaswi Vengalasetti, Niyousha Naderi, Christian Vega, et al.
(2022), pp. 112-124
Open Access
Page 1

Scroll to top